Tissue-Free vs Tumor-Informed Circulating Tumor DNA Assays in Early Triple Negative Breast Cancer

Дата публикации: 13-08-2026 00:00:00

This prognostic study compares tissue-free circulating tumor DNA analysis to tissue-free assay with tumor-informed assay results for estimating recurrence in patients with triple negative breast cancer.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Circulating Tumor DNA in Early Breast Cancer	0	9.02	01-07-2026
2	PFS in Metastatic Breast Cancer by Local Investigators vs Blinded Independent Central Review	0	8.34	16-07-2026
3	Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2 -Positive Breast Cancer	0	7	25-06-2026
4	Cemiplimab and Fianlimab With Neoadjuvant Chemotherapy in Early-Stage High-Risk Breast Cancer	0	18.85	30-07-2026
5	When Not to Push the Boulder	0	5	02-07-2026
6	Troponin Screening and Major Cardiovascular Adverse Events During ICI Therapy	0	7.02	21-07-2026
7	‘Liquid biopsy’ tech contributes to successful clinical trial for detecting breast cancer recurrence	0	6.61	29-07-2020
8	Pathologic Response After Neoadjuvant Chemoimmunotherapy in Head and Neck Squamous Cell Carcinoma	0	4.44	13-08-2026
9	Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors	0	7	25-06-2026
10	Anti-Müllerian hormone predicts benefit of chemo + endocrine therapy in under-55s with breast cancer	0	12.26	12-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 12.99. Источник: archderm.jamanetwork.com.